Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 3/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.46 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14049277 | 0.86 | MEN1 (0.67) | MEN1KMT2ACNR1LMNAPKM | |
| SCHEMBL14086890 | 0.85 | KMT2A (0.71) | MEN1KMT2ACNR1LMNAPKM | |
| SCHEMBL19401562 | 0.85 | ALDH1A1 (0.61) | MEN1KMT2ACNR1LMNAPKM | |
| SCHEMBL21227418 | 0.84 | ALDH1A1 (0.59) | MEN1KMT2ACNR1ANPEPDNPEP | |
| SCHEMBL7257878 | 0.83 | ALDH1A1 (0.58) | CNR1LMNAPKMANPEPRNPEP | |
| SCHEMBL31035882 | 0.83 | MEN1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL15855122 | 0.83 | MEN1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL29040294 | 0.83 | MEN1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL15855121 | 0.83 | MEN1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL8847608 | 0.82 | CNR1 (0.57) | CNR1LMNAPKMANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114557348-B | Sex attractant for bactrocera dorsalis and application thereof | 哈尔滨学院 | 2023-08-04 | — | — | CN | claimed |
| CN-114557348-A | Sex attractant for bactrocera dorsalis and application thereof | 哈尔滨学院 | 2022-05-31 | — | — | CN | claimed |
| WO-2023215740-A1 | IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES | SEAGEN INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-20230346969-A1 | INTERMEDIATE FOR PREPARING ANTIBODY-DRUG CONJUGATE (ADC), PREPARATION METHOD THEREFOR, AND USE THEREOF | DARTSBIO PHARMACEUTICALS LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-114557348-B | Sex attractant for bactrocera dorsalis and application thereof | 哈尔滨学院 | 2023-08-04 | — | — | CN | disclosed |
| CN-114557348-B | Sex attractant for bactrocera dorsalis and application thereof | 哈尔滨学院 | 2023-08-04 | — | — | CN | disclosed |
| EP-3498724-B1 | NUCLEIC ACID COMPLEX | KYOWA KIRIN CO LTD (JP) | 2023-06-21 | — | — | EP | disclosed |
| US-20230123569-A1 | COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | LIGACHEM BIOSCIENCES INC. (KR) | 2023-04-20 | — | — | US | disclosed |
| WO-2022232195-A2 | COVALENT APTAMERS | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-11-03 | — | — | WO | disclosed |
| CN-114557348-A | Sex attractant for bactrocera dorsalis and application thereof | 哈尔滨学院 | 2022-05-31 | — | — | CN | disclosed |
| CN-114557348-A | Sex attractant for bactrocera dorsalis and application thereof | 哈尔滨学院 | 2022-05-31 | — | — | CN | disclosed |
| US-20080125581-A1 | Methods and compositions for controlled polypeptide synthesis | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2008-05-29 | — | — | US | disclosed |
| US-7329727-B2 | Methods and compositions for controlled polypeptide synthesis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-02-12 | — | — | US | disclosed |
| US-7329727-B2 | Methods and compositions for controlled polypeptide synthesis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-02-12 | — | — | US | disclosed |
| US-7160890-B2 | Compounds specific to adenosine A3 receptor and uses thereof | OSI PHARMACEUTICALS, INC. (US) | 2007-01-09 | — | — | US | disclosed |
| US-6680324-B2 | 4-AMINO-6-PHENYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES | OSI PHARMACEUTICALS, INC. | 2004-01-20 | — | — | US | disclosed |
| US-5614519-A | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists | KARL THOMAE GMBH (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5602127-A | ADMINISTERING TO TREAT HYPERTENSION | KARL THOMAE GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346969-A1 | INTERMEDIATE FOR PREPARING ANTIBODY-DRUG CONJUGATE (ADC), PREPARATION METHOD THEREFOR, AND USE THEREOF | WEE1, THEM6, KIF11 | MEN1 859/4885KMT2A 3099/4885CNR1 2322/4885 |
| US-20230123569-A1 | COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | ENPP2, PLA2G10, LPCAT1 | MEN1 1247/4885KMT2A 1905/4885CNR1 578/4885 |
| US-20080125581-A1 | Methods and compositions for controlled polypeptide synthesis | NGLY1, LNPEP, NPPA | MEN1 1163/4885KMT2A 3018/4885CNR1 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.